Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001851

Options or other derivatives

  • Director acquired 77,695 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walts Alan Edmund · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-04-01 Grant or award : show line 1 in the form Restricted Stock Units +37,695 37,695 D
2021-04-01 Grant or award : show line 2 in the form Stock Options (Right to Buy) +40,000 40,000 D
Loading xslF345X03/form4-04022021_060410.xml…